Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects
This study is ongoing, but not recruiting participants.
Sponsor:
PharmAthene, Inc.
Collaborators:
Information provided by:
PharmAthene, Inc.
ClinicalTrials.gov Identifier:
NCT01265745
First received: December 17, 2010
Last updated: June 6, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2011 |
| Estimated Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |